Comparative Effects of Spider Cage Therapy and Modified Suit Therapy in CP

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-01

Study Completion Date

2024-02-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Spider Cage is a part of universal exercise unit. It is a suspension system, which works with use of belts, elastic cords and Thera suits (Thera suits especially for cerebral palsy). Cords are dynamic and provides an appropriate amount of support with the help of which patient can perform movement independently. Cerebral Palsy (CP) is a condition where non progressive disorders of posture caused by abnormal development of, or damage to, motor control centers of brain resulting in abnormal movements.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of Universal Exercise Unit Therapy With Task-oriented Training in CP Children

NCT06637579

Cerebral Palsy Children

RECRUITING NA

Pelvic Neuromuscular Facilitation and Swiss Ball Exercises on Trunk Control in Children With Diaplegic CP

NCT05460923

Cerebral Palsy

UNKNOWN NA

Dual Task Training in Spastic Cerebral Palsy

NCT06407856

Spastic Cerebral Palsy

COMPLETED NA

Effect of Core Stability Exercises With and Without Kinesio-Taping in CP Children

NCT06198127

Spastic Cerebral Palsy

COMPLETED NA

Whole Body Vibration and BOSU Ball in Spastic Cerebral Palsy

NCT06407921

Spastic Cerebral Palsy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

It will be Randomized Controlled trial in which non probability convenience sampling technique will be used. Two groups of 8 to 12 age will be formed in which participants will be randomly divided by lottery method. Group A will be given modified Thera suits and the other group B will receive spider cage therapy on trunk stability and pelvic control. Improvement will be identified by Trunk Control Measurement Scale (TCMS), Trunk impairment scale (TIS) and Gross motor function classification system. (GMFCS) level I-II. The result after statistical analysis will show that which treatment will be more effective. Results will be analyzed on SPSS 29. Data analyzed by repeated measures ANOVA

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

It will be Randomized Controlled trial in which non probability convenience sampling technique will be used. Two groups of 8 to 12 age will be formed in which participants will be randomly divided by lottery method. Group A will be given modified Thera suits and the other group B will receive spider cage therapy on trunk stability and pelvic control.

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Participants will get seperate treatment protocols and possible efforts will be put to mask the both groups about their treatment.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group A

Spider cage therapy along with strengthening exercises

Group Type ACTIVE_COMPARATOR

spider cage

Intervention Type DEVICE

5 days a week for an hour/daily with conventional exercises. Assisted sit to stand (10 to 15---15 to 20) Assisted weight shift (10 to 15---15 to 20) Assisted trunk rotation (10 to 15---15 to 20) Hip Abd / Add. exercises (10 to 15---15 to 20) Bridge exercises (10 to 15---15 to 20)

group B

Modified suits therapy along with strengthening exercise

Group Type ACTIVE_COMPARATOR

modified suits therapy

Intervention Type DEVICE

5 days a week for an hour/daily with conventional exercises. Assisted sit to stand (10 to 15---15 to 20) Assisted weight shift (10 to 15---15 to 20) Assisted trunk rotation (10 to 15---15 to 20) Hip Abd / Add. exercises (10 to 15---15 to 20) Bridge exercises (10 to 15---15 to 20)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

spider cage

5 days a week for an hour/daily with conventional exercises. Assisted sit to stand (10 to 15---15 to 20) Assisted weight shift (10 to 15---15 to 20) Assisted trunk rotation (10 to 15---15 to 20) Hip Abd / Add. exercises (10 to 15---15 to 20) Bridge exercises (10 to 15---15 to 20)

Intervention Type DEVICE

modified suits therapy

5 days a week for an hour/daily with conventional exercises. Assisted sit to stand (10 to 15---15 to 20) Assisted weight shift (10 to 15---15 to 20) Assisted trunk rotation (10 to 15---15 to 20) Hip Abd / Add. exercises (10 to 15---15 to 20) Bridge exercises (10 to 15---15 to 20)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • 8 to 12 years of age

* Both male and female
* Hemiplegic cerebral palsy according to (GMFCS) severity level I-II
* Ability to follow instructions and participate in therapy session

Exclusion Criteria

* • Presence of any medical conditions that would severely limit a child's participation in the study as vision or hearing loss, cardiac anomalies.

* severe cognitive impairments that would hinder the participant's ability to actively participate in therapy sessions.
* Complicated systemic disorders.
* Uncontrollable seizures.
* Usage of Botulinum toxin A injection within 3 months of prior

Minimum Eligible Age

8 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No